Annals of Behavioral Medicine

, Volume 19, Issue 2, pp 83–90

Alzheimer caregiver stress: Basal natural killer cell activity, pituitary-adrenal cortical function, and sympathetic tone

  • Michael Irwin
  • Richard Hauger
  • Thomas L. Patterson
  • Shirley Semple
  • Michael Ziegler
  • Igor Grant
Mini-Series

Abstract

The association between Alzheimer caregiving and natural killer (NK) cell activity and basal plasma levels of adrenocorticotropic hormone (ACTH), cortisol, β-endorphin, prolactin, epinephrine, norepinephrine, and neuropeptide Y was determined in 100 spousal Alzheimer caregivers and 33 age-and gender-comparable control volunteers upon intake into a study of the psychological and physiologic impact of caregiving. The relationship between these physiologic measures and individual characteristics such as age, gender, medical status, severity of stress, severity of depressive symptoms, and caregiver burden was tested. In addition, the association between NK activity and alterations of the neuroendocrine measures was investigated. As compared to controls, the Alzheimer caregivers had similar levels of NK activity and of basal plasma neuroendocrine hormones and sympathetic measures. While older age and male gender status were associated with increased levels of ACTH, neither medical caseness, severity of life stress, nor severity of depressive symptoms was associated with alterations in any of the multiple physiologic domains. Classification of Alzheimer caregiver burden identified caregivers who were mismatched in terms of the amount of care they were required to provide and the amount of respite time received. The mismatched caregivers had significantly higher basal plasma ACTH but no change in other physiological measures, as compared to non-mismatched caregivers. NK activity was negatively correlated with plasma levels of neuropeptide Y but not with any of the other neuroendocrine measures. Based on this cross-sectional evaluation of NK activity and neuroendocrine and sympathetic measures, we conclude that most Alzheimer caregivers do not show evidence of altered basal physiology.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. (1).
    Irwin M, Patterson T, Smith TL, et al: Reduction of immune function in life stress and depression.Biological Psychiatry. 1990,27:22–30.PubMedCrossRefGoogle Scholar
  2. (2).
    Kiecolt-Glaser JK, Glaser R: Stress and immune function in humans. In Ader R, Felten D, Cohen N (eds),Psychoneuroimmunology. San Diego, CA: Academic Press, 1991, 849–867.Google Scholar
  3. (3).
    Irwin M, Daniels M, Bloom ET, Smith TL, Weiner H: Life events, depressive symptoms, and immune function.American Journal of Psychiatry. 1987,144(4):437–441.PubMedGoogle Scholar
  4. (4).
    Trinchieri G: Biology of natural killer cells.Advances in Immunology. 1989,47:187–376.PubMedGoogle Scholar
  5. (5).
    Levy SM, Fernstrom J, Herberman RB, et al: Persistently low natural killer cell activity and circulating levels of plasma beta endorphin: Risk factors for infectious disease.Life Sciences. 1991,48:107–116.PubMedCrossRefGoogle Scholar
  6. (6).
    Irwin M, Brown M, Patterson T, et al: Neuropeptide Y and natural killer cell activity: Findings in depression and Alzheimer caregiver stress.FASEB Journal. 1991,5:3100–3107.PubMedGoogle Scholar
  7. (7).
    Esterling BA, Kiecolt-Glaser JK, Bodnar JC, Glaser R: Chronic stress, social support, and persistent alterations in the natural killer cell response to cytokines in older adults.Health Psychology. 1994,13:291–298.PubMedCrossRefGoogle Scholar
  8. (8).
    Herbert TB, Cohen S: Stress and immunity in humans: A meta-analytic review.Psychosomatic Medicine. 1993,55:364–379.PubMedGoogle Scholar
  9. (9).
    Schleifer SJ, Keller SE, Bond RN, Cohen J, Stein M: Major depressive disorder and immunity: Role of age, sex, severity, and hospitalization.Archives of General Psychiatry. 1989,46:81–87.PubMedGoogle Scholar
  10. (10).
    Evans DL, Folds JD, Petitto JM, et al: Circulating natural killer cell phenotypes in men and women with major depression.Archives of General Psychiatry. 1992,49:388–395.PubMedGoogle Scholar
  11. (11).
    Miller AH, Asnis GM, Lackner C, Halbreich U, Norin AJ: Depression, natural killer cell activity, and cortisol secretion.Biological Psychiatry. 1991,29:878–886.PubMedCrossRefGoogle Scholar
  12. (12).
    Friedman SB, Mason JW, Hamburg DA: Urinary 17-hydroxycortico-steroid levels in parents of children with neoplastic disease: A study of chronic psychological stress.Psychosomatic Medicine. 1963,25:364–376.PubMedGoogle Scholar
  13. (13).
    Wolff CT, Friedman SB, Hofer MA, Mason JW, Hamburg DA: Relationship between psychological defenses and mean urinary 17-OHCS excretion rates: I. A predictive study of parents of fatally ill children.Psychosomatic Medicine. 1964,26:576–585.PubMedGoogle Scholar
  14. (14).
    Rose RM: Endocrine responses to stressful psychological events.Psychiatric Clinics of North America 1980,3:251–276.Google Scholar
  15. (15).
    Hamburg DA: Plasma and urinary corticosteroid levels in naturally occurring psychologic stresses.Research Publications—Association for Research in Nervous and Mental Disease. 1962,40:406–413.PubMedGoogle Scholar
  16. (16).
    Brantley PJ, Dictz LS, McKnight GT, Jones GN, Tulley R: Convergence between the daily stress inventory and endocrine measures of stress.Journal of Consulting and Clinical Psychology. 1988,56:549–551.PubMedCrossRefGoogle Scholar
  17. (17).
    Rose RM: Normality and stress: Response and adaptation from an endocrine perspective. In Offer D, Sabshin M (eds),The Diversity of Normal Behavior. New York: Basic Books, 1991, 60–87.Google Scholar
  18. (18).
    Irwin M, Daniels M, Risch SC, Bloom E, Weiner H: Plasma cortisol and natural killer cell activity during bereavement.Biological Psychiatry. 1988,24:173–178.PubMedCrossRefGoogle Scholar
  19. (19).
    Jacobs SC, Mason JW, Kosten TR, et al: Bereavement and catecholamines.Journal of Psychosomatic Research. 1986,30:489–496.PubMedCrossRefGoogle Scholar
  20. (20).
    Rose RM, Fogg LF: Definition of a responder: Analysis of behavioral, cardiovascular, and endocrine responses to varied workload in air traffic controllers.Psychosomatic Medicine. 1993,55:325–338.PubMedGoogle Scholar
  21. (21).
    Johnson EO, Kamilaris TC, Chrousos GP, Gold PW: Mechanisms of stress: A dynamic overview of hormonal and behavioral homeostasis.Neuroscience and Biobehavioral Reviews. 1992,16:115–140.PubMedCrossRefGoogle Scholar
  22. (22).
    Rose RM, Jenkins CD, Hurst M, Herds JA, Hall RD: Endocrine activity in air traffic controllers at work: II. Biological, psychological and work correlates.Psychoneuroendocrinology. 1982,7:113–123.PubMedCrossRefGoogle Scholar
  23. (23).
    Yehuda R, Giller EL, Southwick SM, Lowy MT, Mason JW: Hypothalamic-pituitary-adrenal dysfunction in posttraumatic stress disorder.Biological Psychiatry. 1991,30:1031–1048.PubMedCrossRefGoogle Scholar
  24. (24).
    Chrousos GP: The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation.New England Journal of Medicine. 1995,332:1351–1362.PubMedCrossRefGoogle Scholar
  25. (25).
    Yehuda R, Kahana B, Binder-Brynes K, et al: Low urinary cortisol excretion in holocaust survivors with posttraumatic stress disorder.American Journal of Psychiatry. 1995,152:982–986.PubMedGoogle Scholar
  26. (26).
    Kronfol Z, House JD: Depression, hypothalamic-pituitary adrenocortical activity, and lymphocyte function.Psychopharmacology Bulletin. 1985,21:476–478.PubMedGoogle Scholar
  27. (27).
    Darko D, Irwin M, Risch SC, Gillin JC: Plasma beta-endorphin and natural killer cell activity in patients with major depression.Psychiatry Research. 1992,43:111–119.PubMedCrossRefGoogle Scholar
  28. (28).
    Hartmann DP, Holaday JW, Bernton EW: Inhibition of lymphocyte proliferation by antibodies to prolactin.FASEB Journal. 1989,3:2194–2202.PubMedGoogle Scholar
  29. (29).
    Darko DF, Gillin JC, Risch SC, et al: Mitogen-stimulated lymphocyte proliferation and pituitary hormones in major depression.Biological Psychiatry. 1989,26:145–155.PubMedCrossRefGoogle Scholar
  30. (30).
    Clodi M, Svoboda T, Kotzmann H, et al: Effect of elevated serum prolactin concentrations on cytokine production and natural killer cell activity.Neuroendocrinology. 1992,56:775–779.PubMedCrossRefGoogle Scholar
  31. (31).
    Hollingshead AB:Two Factor Index of Social Position. New Haven, CT: AB Hollingshead, 1957.Google Scholar
  32. (32).
    Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL: A new clinical scale for the staging of dementia.British Journal of Psychiatry. 1982,140:566–572.PubMedCrossRefGoogle Scholar
  33. (33).
    Grant I, Brown G, Harris T, McDonald W: Severely threatening events and marked life difficulties preceeding onset or exacerbation of multiple sclerosis.J Neurol Neurosurg. 1989,52:8–13.Google Scholar
  34. (34).
    Brown GW, Harris TO, Hepworth C: Life events and endogenous depression.Archives of General Psychiatry. 1994,51:525–534.PubMedGoogle Scholar
  35. (35).
    Beck AT:Depression: Clinical, Experimental, and Theoretical Aspects. New York: Harper and Row, 1967.Google Scholar
  36. (36).
    Hamilton M: A rating scale for depression.Journal of Neurology, Neurosurgery and Psychiatry. 1960,23:56–62.Google Scholar
  37. (37).
    Grant I, Patterson TL, Yager J: Social supports in relation to physical health and symptoms of depression in the elderly.American Journal of Psychiatry. 1988,145(10):1254–1258.PubMedGoogle Scholar
  38. (38).
    Plotsky PM, Thrivikraman KV, Watts AG, Hauger RL: Hypothalamic-pituitary-adrenal axis function in the Zucker obese rat.Endocrinology. 1992,130:1931–1941.PubMedCrossRefGoogle Scholar
  39. (39).
    Zahradnik R, Brennan G, Hutchison JS, Odell WD: Immunoradiometric assay of corticotropin with use of avidin-biotin separation.Clinical Chemistry. 1989,35:804–807.PubMedGoogle Scholar
  40. (40).
    Lisansky J, Hauger R, Strassman R, et al: β-endorphin response to a low dosage of human corticotropin releasing hormone during metyrapone administration in depression.Endocrine Research. 1992,18:241–260.PubMedGoogle Scholar
  41. (41).
    Hiemke C, Brunner R, Hammes E, et al: Circadian variations in antigen-specific proliferation of human T lymphocytes and correlation to cortisol production.Psychoneuroendocrinology. 1995,20: 335–342.PubMedCrossRefGoogle Scholar
  42. (42).
    Kiecolt-Glaser JK, Glaser R, Gravenstein S, Malarkey WB: Chronic stress alters the immune response to influenza virus vaccine in older adults.Proceedings of the National Academy of Science. 1996,93:3043–3047.CrossRefGoogle Scholar
  43. (43).
    Irwin M, Daniels M, Smith TL, Bloom E, Weiner H: Impaired natural killer cell activity during bereavement.Brain, Behavior, and Immunity. 1987,1:98–104.PubMedCrossRefGoogle Scholar
  44. (44).
    Zisook S, Shuchter SR, Irwin M, et al: Bereavement, depression, and immune function.Psychiatry Research. 1995,52:1–10.CrossRefGoogle Scholar
  45. (45).
    Kiecolt-Glaser JK, Glaser R, Dyer C, et al: Chronic stress and immunity in family caregivers of Alzheimer’s disease victims.Psychosomatic Medicine. 1987,49:523–535.PubMedGoogle Scholar
  46. (46).
    Kiecolt-Glaser JK, Glaser R, Shuttleworth EC, et al: Chronic stress and immunity in family caregivers of Alzheimer’s disease victims.Psychosomatic Medicine. 1991,49(5):523–535.Google Scholar
  47. (47).
    Kiecolt-Glaser JK, Dura JR, Speicher CE, Trask OJ, Glaser R: Spousal caregivers of dementia victims: Longitudinal changes in immunity and health.Psychosomatic Medicine. 1991,53:345–362.PubMedGoogle Scholar
  48. (48).
    Hauger RL, Thrivikraman KV, Plotsky PM: Age-related alterations of hypothalamic-pituitary-adrenal axis function in male Fischer 344 rats.Endocrinology. 1994,134:1528–1536.PubMedCrossRefGoogle Scholar
  49. (49).
    Irwin M, Hauger R, Brown M: Central corticotropin releasing hormone activates the sympathetic nervous system and reduces immune function: Increased responsivity of the aged rat.Endocrinology. 1992,131:1047–1053.PubMedCrossRefGoogle Scholar
  50. (50).
    Kutza J, Kaye D, Murasko DM: Basal natural killer cell activity of young versus elderly humans.Journal of Gerontology. 1995,50A: B110-B116.Google Scholar
  51. (51).
    Hauger RL, Lorang M, Irwin M, Aguilera G: CRF receptor regulation and sensitization of ACTH responses to acute ether stress during chronic intermittent immobilization stress.Brain Research. 1990,532:34–40.PubMedCrossRefGoogle Scholar
  52. (52).
    Pike JL, Smith TL, Hauger RL, et al: Chronic life stress alters sympathetic, neuroendocrine, and immune responsivity to an acute psychological stressor in humans.Psychosomatic Medicine. 1997,59:447–457.PubMedGoogle Scholar
  53. (53).
    Fawzy FI, Fawzy NW, Hyun CS, et al: Malignant melanoma: Effects of an early structured psychiatric intervention, coping, and affective state on recurrence and survival six years later.Archives of General Psychiatry. 1993,50(9):681–689.PubMedGoogle Scholar

Copyright information

© The Society of Behavioral Medicine 1997

Authors and Affiliations

  • Michael Irwin
    • 1
  • Richard Hauger
    • 1
  • Thomas L. Patterson
    • 1
  • Shirley Semple
    • 1
  • Michael Ziegler
    • 1
  • Igor Grant
    • 1
  1. 1.Department of Psychiatry (116A)UCSD/VAMCSan Diego

Personalised recommendations